Skip to main content
TipRanks
Go Ultimate75% OFF

BridgeBio Oncology Therapeutics (BBOT) Income Statement

79 Followers

BridgeBio Oncology Therapeutics Income Statement

Last quarter (Q3 2026), BridgeBio Oncology Therapeutics's total revenue was $0.00. In Q3, BridgeBio Oncology Therapeutics's net income was $-34.18M. See BridgeBio Oncology Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 145.82M$ 80.86M$ 64.77M$ 3.52K$ 43.36K
Depreciation and Amortization$ 610.00K$ 208.00K$ 92.00K$ 3.52K$ 0.00
$ -145.21M$ -80.66M$ -64.68M$ 0.00$ -43.36K
$ -145.82M$ -80.86M$ -64.77M$ -3.52K$ -43.36K
$ 11.78M$ 6.59M$ 72.00K$ 0.00$ 0.00
$ -134.04M$ -74.28M$ -64.70M$ -3.52K$ -43.36K
$ -134.04M$ -74.28M$ -64.70M$ -3.52K$ -43.36K
Per Share Metrics
Basic EPS$ -4.30$ -5756.41$ -0.00$ 0.00$ -0.00
Diluted EPS$ -4.30$ -5756.41$ -3.16$ -0.00$ -0.00
Weighted Average Shares Outstanding31.14M12.90K20.48M20.48M20.48M
Weighted Average Shares Outstanding (Diluted)31.14M12.90K20.48M20.48M20.48M

Currency in USD

BridgeBio Oncology Therapeutics Earnings and Revenue History

-150M-100M-50M00 %0.4 %0.8 %1.2 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin